Abstract
The authors prospectively screened 297 patients with Parkinson disease (PD), who attended a tertiary clinic, using a modified South Oaks Gambling Scale. Lifetime prevalence of pathologic gambling (PG) was 3.4% and on any dopamine agonist was 7.2%. PG was associated with earlier PD onset and with dopamine agonists but not with agonist subtype or doses. We found no association with a potent D3 receptor agonist.
Publication types
- Controlled Clinical Trial
MeSH terms
- Aged
- Antiparkinson Agents / therapeutic use*
- Dopamine Agents / therapeutic use*
- Female
- Gambling*
- Humans
- Levodopa / therapeutic use*
- Male
- Middle Aged
- Ontario / epidemiology
- Parkinson Disease / drug therapy*
- Parkinson Disease / epidemiology*
- Prevalence
- Prospective Studies
- Risk Assessment / methods*
- Risk Factors
Substances
- Antiparkinson Agents
- Dopamine Agents
- Levodopa